REVELATION BIOSCIENCES INC
COM NEW 2025 · CUSIP 76135L705
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2025 | 1 |
| Q3 2025 | 10 |
| Q4 2025 | 13 |
| Q1 2026 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2025 | 9 | 1 |
| Q4 2025 | 12 | 5 |
| Q1 2026 | 0 | 12 |
Biggest buyers
| None |
Biggest sellers
| SABBY MANAGEMENT, LLC | Sold out | -605.7k |
| ARMISTICE CAPITAL, LLC | Sold out | -434.3k |
| CITADEL ADVISORS LLC | Sold out | -54.7k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -34.0k |
| NORTHERN TRUST CORP | Sold out | -21.9k |
| HRT FINANCIAL LP | Sold out | -15.3k |
| XTX Topco Ltd | Sold out | -11.3k |
| UBS Group AG | Sold out | -724 |
| BANK OF AMERICA CORP /DE/ | Sold out | -47 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | Sold out | -38 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| SABBY MANAGEMENT, LLC 13G · passive investor new · filed 2026-01-20 | 9.6% |
Fell to 5% or below in the last year: ARMISTICE CAPITAL, LLC (5.0%, 2026-02-17)
Holders, Q1 2026
| Manager | Shares | Change |
|---|